You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
McKinsey
Merck
Express Scripts
McKesson

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

Aspirin; carisoprodol - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for aspirin; carisoprodol and what is the scope of freedom to operate?

Aspirin; carisoprodol is the generic ingredient in five branded drugs marketed by Heritage Pharms Inc, Novast Labs, Oxford Pharms, Sandoz, Watson Labs, Meda Pharms, and Ingenus Pharms Nj, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-two drug master file entries for aspirin; carisoprodol. One supplier is listed for this compound.

Summary for aspirin; carisoprodol
US Patents:0
Tradenames:5
Applicants:7
NDAs:10
Drug Master File Entries: 22
Suppliers / Packagers: 1
DailyMed Link:aspirin; carisoprodol at DailyMed
Paragraph IV (Patent) Challenges for ASPIRIN; CARISOPRODOL
Tradename Dosage Ingredient NDA Submissiondate
SOMA COMPOUND TABLET;ORAL aspirin; carisoprodol 012365

US Patents and Regulatory Information for aspirin; carisoprodol

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Novast Labs CARISOPRODOL AND ASPIRIN aspirin; carisoprodol TABLET;ORAL 040832-001 Jan 7, 2010 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz CARISOPRODOL AND ASPIRIN aspirin; carisoprodol TABLET;ORAL 040116-001 Apr 25, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Meda Pharms SOMA COMPOUND aspirin; carisoprodol TABLET;ORAL 012365-005 Jul 11, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
Heritage Pharms Inc CARISOPRODOL AND ASPIRIN aspirin; carisoprodol TABLET;ORAL 089594-001 Mar 31, 1989 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz CARISOPRODOL, ASPIRIN AND CODEINE PHOSPHATE aspirin; carisoprodol; codeine phosphate TABLET;ORAL 040118-001 Apr 16, 1996 AB RX No Yes   Start Trial   Start Trial   Start Trial
Meda Pharms SOMA COMPOUND W/ CODEINE aspirin; carisoprodol; codeine phosphate TABLET;ORAL 012366-002 Jul 11, 1983 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Moodys
McKesson
Colorcon
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.